Heukelbach, Jorg, Canyon, Deon V., Shaalan, Essam S., and Speare, Richard (2010) Crotamiton. In: Grayson, M. Lindsay, Crowe, Suzanne M., McCarthy, James S., Mills, John, Mouton, Johan W., Norrby, S. Ragnar, Paterson, David L., and Pfaller, Michael A., (eds.) Kucers' The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs. Hodder Arnold, London, UK, pp. 2325-2328.
Image (JPEG) (Book Cover)
- Cover Image
PDF (Published Version)
- Published Version
Restricted to Repository staff only
Crotamiton (N-ethylcrotono-o-toluidide or N-ethyl-o-methylphenyl- 2-hutenamide; Crotamitex®, Eurax®, Euraxil@, Veteusan®) is an unclassified acaricide (scabicide) and insecticide used topically in human and veterinarian medicine (Domenjoz, 1946; Couperus, 1949; Budavari et al., 1996). The substance is a colorless, yellowish oil, soluble in methanol and ethanol. Its molecular formula is C13H17NO, its molecular weight is 203.28, and the molecular structure is shown in Figure 208.1. Crotamiton is available for topical use only. It is used for the treatment of scabies caused by the mite Sarcoptes scabiei, for other mite infestations, for head lice infestations, and for the symptomatic treatment of pruritus. Formulations available on the market usually contain 10% crotamiton. It was first commercialized by Geigy, and marketed for the treatment of scabies in 1946 (Burckhardt and Rymarowicz, 1946; Domenjoz, 1946; Roos et al., 2001). Crotamiton is sometimes erroneously confused with crotamine, a component of the venom in Brazilian rattlesnakes.
|Item Type:||Book Chapter (Teaching Material)|
This chapter is within Part 7 Agents Active Against Ectoparasites
|Date Deposited:||05 May 2011 00:24|
|FoR Codes:||11 MEDICAL AND HEALTH SCIENCES > 1117 Public Health and Health Services > 111799 Public Health and Health Services not elsewhere classified @ 100%|
|SEO Codes:||92 HEALTH > 9204 Public Health (excl. Specific Population Health) > 920499 Public Health (excl. Specific Population Health) not elsewhere classified @ 100%|
Last 12 Months: 7